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Abstract Mutations aVecting the Na+, K+ ATPase alpha
subunit have been implicated in at least two distinct human
diseases, rapid-onset dystonia Parkinsonism (RDP), and
familial hemiplegic migraine (FHM). Over 40 mutations
have been mapped to the human ATP1A2 and ATP1A3
genes and are known to result in RDP, FHM or a variant of
FHM with neurological complications. To develop a geneti-
cally tractable model system for investigating the role of
the Na+, K+ ATPase in neural pathologies we performed
genetic screens in Drosophila melanogaster to isolate loss-
of-function alleles aVecting the Na+, K+ ATPase alpha sub-
unit. Flies heterozygous for these mutations all exhibit
reduced respiration, consistent with a loss-of-function in
the major ATPase. However, these mutations do not aVect
all functions of the Na+, K+ ATPase alpha protein since
embryos homozygous for these mutations have normal
septate junction paracellular barrier function and tracheal
morphology. Importantly, all of these mutations cause neu-
rological phenotypes and, akin to the mutations that cause
RDP and FHM, these new alleles are missense mutations.
All of these alleles exhibit progressive stress-induced loco-
motor impairment suggesting neuromuscular dysfunction,
yet neurodegeneration is observed in an allele-speciWc
manner. Surprisingly, studies of longevity demonstrate that
mild hypomorphic mutations in the sodium pump signiW-
cantly improve longevity, which was veriWed using the
Na+, K+ ATPase antagonist ouabain. The isolation and
characterization of a series of new missense alleles of ATP-
alpha in Drosophila provides the foundation for further
studies of these neurological diseases and the role of
sodium pump impairment in animal longevity.
Introduction
Neurological disorders have a devastating impact on suVer-
ers and their families. For many such diseases, speciWc dis-
ease-causing mutations have been identiWed; yet the
underlying cellular deWcits and speciWc molecular mecha-
nisms remain poorly understood. The use of a tractable
genetic organism to model these diseases has become an
invaluable method of determining the mechanisms underlying
neuropathogenesis of these complex disease states.
ATPalpha (FBgn0002921) encodes the catalytic subunit
of the Na+, K+ ATPase (a.k.a. the sodium pump). Mature
Na+, K+ ATPases are high molecular weight, integral mem-
brane proteins composed of tetramers of the alpha and beta
subunits and may contain auxiliary subunits. These Na+, K+
ATPases are vital for generating and maintaining the elec-
trochemical gradients that drive numerous downstream cel-
lular processes. These proteins are ubiquitously expressed,
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432 Hum Genet (2009) 126:431–447are highly evolutionarily conserved, and are the predomi-
nate users of cellular ATP (Blanco and Mercer 1998;
Lingrel et al. 1997; Lopina 2000; Mobasheri et al. 2000;
Palmgren and Axelsen 1998). Expression and activity of
the Na+, K+ ATPase is exceptionally high within the neuro-
muscular system, and its activity within the brain accounts
for the overwhelming majority of ATP consumption in
animals (Attwell and Laughlin 2001; Beal et al. 1993;
Erecinska and Dagani 1990; Lees 1993). In addition to
maintaining ionic gradients, these proteins are present in
large complexes that function in cell adhesion, polarity, sig-
naling and endocytosis (Cai et al. 2008; Cereijido et al.
2004, 2008; Genova and Fehon 2003; Hilgenberg et al.
2006; Paul et al. 2003; Rajasekaran et al. 2005). In many
cases, these roles do not require ion transport. For example,
in Drosophila, the Na+, K+ ATPase is essential for forma-
tion of septate junctions (SJs), which form paracellular
diVusion barriers analogous to vertebrate tight junction
(Genova and Fehon 2003; Paul et al. 2003). Importantly,
the Na+, K+ ATPase appears to have a structural role in SJs
since catalytic activity is not required either for SJ barrier
function or for the separable function of facilitating lume-
nal secretion of the protein Verm, which is required for
limiting the length of the tubes comprising the tracheal
(airway) system (Paul et al. 2007).
The Na+, K+ ATPase has been implicated in two distinct
neurological disorders: RDP and FHM (Cannon 2004; de
Carvalho Aguiar et al. 2004; Haan et al. 2005; Pietrobon
2007). RDP is a distinct form of dystonia in which patients
experience sudden—often stress induced—onset of Parkin-
sonian symptoms that are unresponsive to standard dopami-
nergic treatments and not associated with typical
Parkinson’s brain pathology. FHM type II is a form of
migraine associated with partial paralysis (hemiplegia) that
is often accompanied by seizures or symptoms of cognitive
dysfunction. These neurological disorders are dominant and
result primarily from speciWc missense mutations. Little is
known about pathogenesis of these complex neurological
diseases and it is currently unclear whether these chronic
diseases might be complicated by degenerative pathology.
We have previously reported that speciWc alleles of ATP-
alpha cause neurological dysfunction, impaired locomo-
tion, reduced longevity, and progressive neurodegeneration
(Palladino et al. 2002, 2003). To develop Drosophila mod-
els of FHM and RDP diseases and enable detailed studies
of disease pathogenesis we performed a genetic screen to
isolate a series of missense alleles of ATPalpha. We have
identiWed and extensively characterized seven new alleles
of ATPalpha. While animals heterozygous for these muta-
tions share some phenotypes with previously described
mutants, such as progressive locomotor deWcits and
mechanical stress-induced paralysis, they also have novel
and allele-speciWc phenotypes. More importantly, we have
identiWed one allele that bears a missense mutation altering
the protein at a highly conserved residue in exactly the
same manner as is known to result in human FHM.
In addition to further developing Drosophila as a model
for investigating neuropathogenic mechanisms resulting
from Na+, K+ ATPase alpha dysfunction, our results reveal
an unexpected role for the Na+, K+ ATPase in regulating
animal longevity. Previous genetic screens for mutants
causing progressive neurodegeneration have resulted in
alleles of ATPalpha that have signiWcantly reduced longev-
ity (Palladino et al. 2003). The alleles reported here were
isolated based upon failure-to-complement null alleles for
viability and were thus not biased toward causing
neurological phenotypes. One resulting mutation results in
a signiWcant reduction in longevity and progressive neuro-
pathology. However, three alleles aVecting the Na+, K+
ATPase result in a striking increase in animal longevity.
Remarkably, this Wnding was phenocopied with ouabain, a
well-described antagonist of the Na+, K+ ATPase ion-trans-
port activity. These Wndings demonstrate a role for Na+, K+
ATPase impairment in increased longevity and additional
data suggest that this eVect is independent of a caloric
restriction mechanism.
Materials and methods
Fly stock maintenance and mutagenesis
Fly stocks were maintained on standard cornmeal-molasses
agar medium at 22–25°C. Isogenized cn bw; ve e males
were mutagenized with ethylmethane sulfonate using stan-
dard methods. Following mutagenesis the males were
mated to TM6 Tb virgins. Tb F1 males were collected and
individually mated to ATPalphaDTS1R1/TM6 Tb or ATPal-
phaDTS2R3/TM6 Tb virgin females. Putative new alleles
were identiWed as those which failed to complement exist-
ing ATPalpha revertant lines for embryonic and early larval
lethality, resulting in a lack of the expected 1/3 Tb+
progeny. Vials were initially screened without magniWcation
for the presence of non-Tb pupal cases. Strains were out-
crossed several times to replace the other mutagenized
chromosomes. ATPalphaCJ strains lacking the cn bw chro-
mosome were identiWed and absence of bw was conWrmed
using genetics and PCR (data not shown). Hybrid animals
bearing Canton S and ve e (mutant or parental control) were
used to control for second site recessive mutations. There is
a possibility of third chromosome dominant modiWers.
Recombination was used to determine whether a lethal
mutation was linked to e (which is tightly linked to ATPalpha)
and complementation tests were performed between all
new alleles and the DTS1R1, DTS2R3, DTS1 or DTS2 alle-
les using lethality and stress-sensitivity (a.k.a. bang123
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largest complementation group were new alleles, which
were named CJ alleles. Other minor complementation
groups failed to complement unlinked sites of either the
ATPalphaDTS1R1 or the ATPalphaDTS2R3 chromosome (but
not both). One allele was determined to be a complex
reciprocal translocation T3:Y and was discarded (data not
shown).
CJ allele sequencing
Genomic DNA from each ATPalphaCJ strain was isolated
from ten Xies (QiaAMP DNA mini kit, Qiagen). ATPalpha
amplicons 1.5–2.0 kb in size were ampliWed with PCR, ver-
iWed on an agarose gel, puriWed using Qiaquick PCR, and
directly sequenced from ATPalphaCJ/TM6, cn bw; ve e, and
TM3/TM6 animals. Heterozygous sequence diVerences
unique to the ATPalphaCJ/TM6 strain were identiWed within
coding regions of the ATPalpha gene with the exception of
ATPalphaCJ7. Polymorphisms known to exist between ve e
and TM6 have been identiWed in each amplicon from the
ATPalphaCJ7 strain, demonstrating the absence of a large
deletion or inversion that would prevent ampliWcation from
the mutant chromosome.
Trachea assays
Tracheal morphology and dye exclusion assays were per-
formed as previously described (Paul et al. 2007). The phe-
notypes of ATPalphaCJ#/ATPalphanull transheterzygotes
and ATPalphaCJ# homozygotes were assessed in embryos
created by mating ATPalphaCJ#/TM6B GMR-YFP males
with ATPalphanull/TM6B GMR-YFP virgin females. TM6B
GMR-YFP described in Le et al. (2007).
Lifespan analyses
Longevity testing
Lifespan data were collected and analyzed as previously
reported (Celotto et al. 2006a,   b). BrieXy, 20–25 Xies were
kept per vial at 25°C, checked daily, and transferred to
fresh media every other day to minimize incidental death.
Deaths were recorded daily and lifespan plots were generated
showing daily percent survivorship over time. Incidental
deaths and escapees were noted and removed from the sur-
vivorship calculations. Longevity was examined from three
independent populations of animals from each genotype,
until its median age was reached and animals were killed
for histological examination. To control for hybrid vigor,
lifespans for mutant and control strains were examined in
females heterozygous for w ve and e generated by a single
mating between isogenic Canton S or isogenic ve e and
the mutant strain, as appropriate. BrieXy, Tb+ F1 progeny
from w;;ATPalphaCJ/TM6 males mated to isogenic Canton
S virgin females or w; ve e males mated with ATPal-
phaDTS1R1/TM6, ATPalphaDTS1/TM6, ATPalphaDTS2/TM6
virgins were examined to maintain heterozygosity of the
recessive w, ve, and e mutations.
Ouabain eVects on longevity
Lifespans of ouabain-treated Xies were performed on three
independent populations of an inbred isogenic Canton S
strain. Water was used as a vehicle and drug was added at
the noted concentrations to a semi-circle piece of Wlter
paper placed on top of the standard Xy media (»9 ml) cov-
ering »50% of the surface area. Flies were transferred to
fresh media every other day and fresh Wlter paper with drug
was applied.
Behavioral analyses
For behavioral testing, female Tb+ F1 progeny from
w;;ATPalphaCJ/TM6 males mated to CS virgin females or
w;;ve e males mated with ATPalphaDTS1R1/TM6, ATPal-
phaDTS1/TM6, ATPalphaDTS2/TM6 virgins were examined
to maintain heterozygosity of the recessive w, ve, and e
mutations.
Conditional locomotor assays
Assays of stress and temperature sensitivity were con-
ducted as described previously (Palladino et al. 2003). For
stress-sensitivity testing, time to recovery following 15 s of
vortexing was recorded on days 3, 10, 20, and 30 after eclo-
sion. For temperature sensitivity testing, Xies were exposed
to 38°C for 7 min in groups of 3–5, and time to Wrst signs of
sensitivity (bottom-dwelling behavior, brief paralysis) to
total paralysis, as well as time to recovery following return
to 22°C (Wrst deliberate movement; walking, grooming,
Xying) were recorded for each Xy. Temperature sensitivity
was also tested on days 3, 10, 20, and 30.
Locomotor assays
For locomotor activity recording, 9–11-day-old female Xies
were entrained to a 12:12 L:D schedule for 3–4 days at
25°C. Flies were then inserted into individual locomotor
activity tubes supplemented with 5% sucrose, 1% agar
media and capped with yarn. Individual Xy activity was
then recorded utilizing the Drosophila Activity Monitoring
(DAM) system monitors and software (Trikinetics, Inc.).
BrieXy, Xy locomotion breaks an infrared beam, and the
number of beam breaks in 1-min bins was recorded and
analyzed using Insomniac 2.0 software. Sleep, deWned as123
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were identiWed and from these, total time awake and asleep
were calculated. Waking activity levels, a useful measure
of hypo/hyperactivity (Wu et al. 2008), were calculated
from the total activity levels (total beam breaks/total time
awake).
Stimulated locomotor assays
Startle stimulation activity was measured from Zeitgeber
time (ZT) 12–14, a time when Xies are normally inactive.
Monitors were wrapped in aluminum foil just prior to lights
oV to block light entry, and removed from the incubator.
Flies were startled by randomly jarring or moving the
monitors, individually or as a group, at least every 3 min.
Flies were allowed to recover for the remainder of the night
and the foil was removed the following morning.
Behavioral rhythm assays
Flies were monitored using the DAM system as above. Once
entrained to a 12:12 (L:D) pattern for 3 days, animals were
shifted to a DD pattern and activity was observed for 3 days.
Population activity patterns were visualized by binning
activity data into 1 h intervals and averaging by genotype.
Circadian activity and anticipation behavior were noted.
Respiration assays
Individual metabolic measurements were performed as pre-
viously described (Celotto et al. 2006a; Libert et al. 2007;
Van Voorhies et al. 2003, 2004). Respiration was measured
on male Xies that were 5–6 days post-emergent. BrieXy,
respiration rates were determined by measuring CO2 pro-
duction from individual Xies maintained in a 2.2 ml glass
sealed chamber Xushed with CO2-free, water-saturated
(100% RH) air. Gas samples were directly injected into a
150 ml/min (§1%) STPD, dry, CO2-free air stream con-
trolled with a mass Xow meter (Sierra Instruments, Monterrey,
CA). A Li-Cor 6251 carbon dioxide gas analyzer (Li-Cor,
Lincoln, NE) was used to analyze the samples (sensitivity
of <0.1 ppm and an accuracy of <1 ppm). Respiration rates
were determined using DATACAN software (Sable Sys-
tems International, Henderson, NV). Individual Xy mass
was determined using a Sartorius M2P microbalance. The
CO2 gas analysis system was zeroed daily against CO2-free
air, and calibrated against a 51 ppm certiWed gas standard
(Air Products, Long Beach, CA).
Western blots
Eight Xy heads were ground by pestle in 50 l 2£ SDS
PAGE sample buVer (4% SDS, 4% beta-mercaptoethanol,
130 mM Tris–HCl pH 6.8, 20% glycerol). The proteins
were resolved by SDS PAGE and transferred onto nitro-
cellulose. Following treatment in 1% milk in PBST the
blots were treated with anti-TPI (1:5000; rabbit polyclonal
FL-249; Santa Cruz Biotechnology) or anti-Na/K ATPase
(1:5000; alpha5; Developmental Studies Hybridoma Bank
(DSHB)). The blots were washed in PBST, incubated in the
appropriate HRP-conjugated secondary antibody, and
developed with an ECL kit (Pierce) as previously described
(Seigle et al. 2008). QuantiWcation of the scanned Wlms was
performed digitally using ImageJ software available from
the National Institutes of Health.
Histology
Aged Xies were collected at their median age (age of »50%
survivorship) from lifespan experiments. Heads and tho-
raxes were dissected and Wxed for 24 h at room temperature
in freshly prepared Carnoy’s Wxative, washed in 70% etha-
nol, processed and embedded in paraYn blocks according
to standard histological procedures as previously published
(Fergestad et al. 2008; Palladino et al. 2000). Serial 4–5
micron frontal head sections and thoracic cross sections
were obtained and stained with hematoxylin and eosin.
Incidence and extent of pathology present in neural tissues
or Xight muscle, were noted (n > 15 animals per genotype).
Neuropathology was scored on a scale from 0 to 5 using
published methods and criteria (Fergestad et al. 2006).
Feeding assays
Outcrossed male Xies were collected from underpopulated
vials and feeding assays were performed using 3–5-day-
old animals using dyed food consisting of 15% sucrose,
1% agar, and 3% FD&C blue #1 (McCormick). The dye
accumulates in the gut and can be used as a quantitative
measure of meal size (Edgecomb et al. 1994; Xu et al.
2008). Flies were segregated from nutrients for 1 h and
then permitted 2 h to feed. Flies were immediately frozen
on dry ice, separated into groups of 30, and decapitated to
prevent eye pigment interference. Headless bodies were
homogenized in 250 l of PBS. Samples were centrifuged
twice at »15,000g for 15 min to remove debris. Absor-
bance of the supernatant (150 l) was measured at 625 nm
using a plate reader. Absorbance from control age-
matched Xies fed an undyed sucrose–agar mixture was
subtracted, and the net absorbance reXected total food
ingested. SigniWcance was set at P < 0.01 using a Stu-
dent’s t test. The positive controls were wild-type animals
that were not nutrient deprived prior to the assays and
were allowed one-third of the total feeding time, in order
to demonstrate the sensitivity of the assay to detect reduc-
tions in feeding.123
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Isolation of novel, dominant alleles of ATPalpha
Mutations aVecting the ATPalpha gene in Drosophila have
previously been isolated by several labs and cause pheno-
types that include stress-sensitivity, temperature-sensitive
paralysis, reduced longevity and altered tracheal develop-
ment (Genova and Fehon 2003; Lebovitz et al. 1989; Palla-
dino et al. 2002, 2003; Paul et al. 2003; Schubiger et al.
1994; Sun et al. 2001; Trotta et al. 2004). Although several
ATPalpha mutants have been reported, the vast majority of
these are of limited utility for disease modeling and struc-
ture–function studies. Recent publications have identiWed
more than 40 missense mutations aVecting sodium pump
genes are the cause of RDP and FHM diseases. In an eVort
to identify Drosophila missense mutations aVecting ATPalpha
that would model these neurological diseases, a genetic
screen was performed to isolate novel missense alleles of
ATPalpha. Molecular null alleles of ATPalpha that cause
homozygous embryonic lethality were previously identiWed
as revertants of dominant temperature sensitive (DTS)
mutations (e.g. ATPalphaDTS1R1 or ATPalphaDTS2R3) (Palla-
dino et al. 2003; Paul et al. 2003). As these null alleles fail-
to-complement all tested ATPalpha mutations for viability,
including the partial loss-of-function mutations, we rea-
soned that new loss-of-function alleles could be identiWed
as those that fail-to-complement either ATPalphaDTS1R1 or
ATPalphaDTS2R3 for viability. Such a screen would avoid
the bias toward neural or tracheal phenotypes that have
been present in previous screens for ATPase mutations. In
total »12,000 EMS-generated mutant lines were generated
and screened for those that failed to complement either
ATPalphaDTS1R1 or ATPalphaDTS2R3 null mutations for via-
bility. The screen resulted in eight new alleles named CJ for
the student who performed the pilot screen. Recombination
mapping of the lethality demonstrated a tight linkage to
ebony(e) (<1.75 cM) for the ATPalphaCJ4, ATPalphaCJ6,
ATPalphaCJ10, and ATPalphaCJ13 alleles (data not shown).
ATPalphaCJ5, ATPalphaCJ7 and ATPalphaCJ12 had reces-
sive lethal mutations that were not linked to e or ATPalpha.
ATPalphaCJ3 was found to have a T3:Y reciprocal translo-
cation bearing the ATPalpha region and was discarded
from further study.
To further test the allelic nature of the novel ATPalpha
strains, complementation tests for recessive lethality were
performed for all pair-wise combinations (Table 1). All
but ATPalphaCJ7 failed to complement both loss-of-func-
tion alleles ATPalphaDTS1R1 and ATPalphaDTS2R3 for
lethality. ATPalphaCJ4, ATPalphaCJ5, ATPalphaCJ6, ATP-
alphaCJ10, and ATPalphaCJ13 failed to complement each
other as well, resulting in lethality. ATPalphaCJ12 was
lethal in combination with ATPalphaCJ10 and ATPal-
phaCJ13. ATPalphaCJ7 failed to complement ATPalphaCJ4,
ATPalphaCJ6 and ATPalphaCJ13 and produced fewer than
the Mendelian expected progeny with three other alleles,
all in a temperature-dependent manner (Table 1). Ani-
mals that complemented for lethality were tested for
stress-sensitive paralysis. The genetic analyses suggested
that this complementation group represents novel ATPal-
pha alleles. The genetic analysis also demonstrates that
four alleles are not lethal with the entire complementation
group but exhibit markedly reduced viability or condi-
tional lethality with certain other alleles suggesting that
ATPalphaCJ4, ATPalphaCJ6, ATPalphaCJ7 and ATPal-
phaCJ12 are likely mild hypomorphic alleles. The data
could indicate that there is some degree of intragenic
complementation within ATPalphaCJ4/CJ12 and ATPal-
phaCJ6/CJ12 animals. Further data will be needed to resolve
these possibilities.
Table 1 Viability of existing ATPalpha alleles with new missense mutants
Viability to adulthood of each genotype combination at 25°C. Complementation was also examined at 29°C, diVerences from 25°C data are noted.
L is developmental lethal. An asterisk indicates adult viable but a signiWcant reduction from the Mendelian expected one-third of total adults
(P < 0.05). Two asterisks indicate a more severe reduction and only rare escapers were observed. BS, bang or stress-sensitive paralysis
TS Temperature-sensitive paralysis (38°C)
DTS1R1 DTS2R3 CJ 4 CJ 5 CJ 6 CJ 7 CJ 10 CJ 12 CJ 13
+ BS BS BS BS BS BS BS, TS BS BS
DTS1R1 L L L L L BS L L L
DTS2R3 L L L L BS L L L
CJ 4 L L L BS**, L29 L BS**, L29 L
CJ 5 L L BS**29 L L L
CJ 6 L BS, L29 L BS L
CJ 7 L BS**29 BS*,**29 BS, L29
CJ 10 L L L
CJ 12 L L**29
CJ 13 L123
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The above genetic data strongly suggest that several novel
ATPalpha alleles have been isolated. To conWrm this, we
directly sequenced PCR amplicons covering the major cod-
ing regions of ATPalpha from each mutant and two control
strains. We discovered mutations in six of the seven strains
and, in all cases, these were missense mutations (Fig. 1;
Supplemental Fig. 1). These mutations did not correspond
with any polymorphisms found between the two control
sequences (ve e and TM6) and each alters a highly con-
served amino acid among species from hydra to human
(Supplemental Fig. 2). We did not Wnd a mutation within
the coding sequences of the CJ7 allele. It is possible that
this mutation aVects non-coding sequences or a diVerent
gene that interacts with ATPalpha, possibly by reducing its
expression (see Fig. 2b).
The molecular and complementation data provide evi-
dence that the CJ alleles aVect ATPalpha and that at least
six of the new alleles directly alter the encoded protein.
Fig. 1 Pathogenic mutations aVecting Na, K ATPase alpha subunits.
A 3.5 Å crystal structure of the Na, K ATPase as a dimer is available
(Morth et al. 2007). Numbered amino acids indicate those known to be
aVected by pathogenic mutations in the human ATP1A2 (FHM), hu-
man ATP1A3 (RDP), or Drosophila ATPalpha genes. These residues
have been mapped onto a common structure for clarity. Citations for
human ATP1A2 mutations: Ambrosini et al. (2005), Castro et al.
(2008), De Fusco et al. (2003), Fernandez et al. (2008), Gallanti et al.
(2008), Jen et al. (2007), Jurkat-Rott et al. (2004), Kaunisto et al.
(2004), Koenderink et al. (2005), Pierelli et al. (2006), Riant et al.
(2005), Segall et al. (2004, 2005), Spadaro et al. (2004), Swoboda
et al. (2004), Todt et al. (2005), Vanmolkot et al. (2003, 2006a, b,
2007). Citations for human ATP1A3 mutations: Brashear et al. (2007),
de Carvalho Aguiar et al. (2004), Kamm et al. (2008), Zanotti-Fregon-
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all point mutations that result in a single amino acid substi-
tution in the ATPalpha protein. Known Na+, K+ ATPases
alpha disease-causing mutations are dominant and appear
to confer a loss-of-function resulting either from haploin-
suYciency or a mild hypomorphic impairment in pump
function (de Carvalho Aguiar et al. 2004; Pietrobon 2007).
To examine the range of impairment caused by these newly
isolated alleles, we assessed the eVects of these mutations
in Wve functional tests and compared the new mutations
with representative previously isolated alleles.
Adult ATPalpha protein expression in mutant alleles
We examined ATPalpha protein expression from ATPal-
phaDTS mutants, their revertants and control animals. All
mutations are homozygous lethal and protein levels were
examined as heterozygotes. Consistent with ATPalphaDTS
mutants resulting in a dominant gain-of-function, these
alleles have normal expression by western blot analysis
(Fig. 2a). The revertant strains all have expression
reduced by 30–50% compared to wild type. These results
are in accordance with those found previously by immu-
nohistochemistry for ATPalphaDTS1 and ATPalphaDTS1R1
(Fergestad et al. 2006). While one might expect a 50%
reduction in protein levels in animals heterozygous for
null ATPase mutations, only ATPalphaDTS1R1 shows this
degree of reduction, suggesting the presence of a compen-
satory mechanism that either stabilizes the protein or
increases its level of expression in the other revertants.
ATPalphaDTS2R2 and ATPalphaDTS2R3 do exhibit signiW-
cantly higher expression than the expected 50% of wild-
Fig. 2 Adult ATPalpha protein 
expression in animals heterozy-
gous for dominant alleles. a Pre-
viously described ATPalpha 
mutants demonstrate a signiW-
cant decrease in expression in 
the revertant lines examined but 
not in the temperature-sensitive 
alleles, compared to wild-type 
controls. ATPalphaDTS2R2 and 
ATPalphaDTS2R3 express signiW-
cantly more protein than the 
50% expected for a heterozy-
gous null (P < 0.05) suggesting 
the possibility of a compensa-
tory mechanism. b Newly iso-
lated missense mutants 
ATPalphaCJ6, ATPalphaCJ7, and 
ATPalphaCJ13 have signiWcantly 
reduced ATPalpha protein rela-
tive to wild-type controls, 
whereas the remaining CJ alleles 
do not have signiWcantly altered 
expression. In all cases: n = 3, 
ATPalpha protein was normal-
ized to the internal control pro-
tein TPI. Error shown is SEM. 
Student t test reduction from 
control: * P < 0.05, ** P < 0.01, 








































































438 Hum Genet (2009) 126:431–447type ATPalpha protein (P < 0.05), whereas, ATPal-
phaDTS1R1 and ATPalphaDTS1R2 do not deviate signiWcantly
from this expected value (P > 0.05). Interestingly, the
ATPalphaDTS1R1 mutation is a four nucleotide deletion
causing a frameshift that introduces a premature stop
codon in an earlier exon, suggesting the possibility that
non-sense mediated decay (NMD) might actively degrade
ATPalphaDTS1R1 mRNAs. Consistent with NMD mRNA
targeting we did not observe a truncated protein product
by western blot.
Protein expression was also examined in the novel ATP-
alphaCJ alleles by western blot. Several alleles, namely
ATPalphaCJ6, ATPalphaCJ7, and ATPalphaCJ13, exhibit a
signiWcant reduction in ATPalpha protein (Fig. 2b). In
contrast, the ATPalphaCJ4, ATPalphaCJ5, ATPalphaCJ10,
and ATPalphaCJ12 mutants do not have signiWcantly altered
ATPalpha protein levels.
Conditional temperature-dependent paralysis
ATPalphaDTS mutants were originally isolated based upon
their temperature-dependent paralysis phenotype. Null
mutations were isolated as revertants of this temperature-
sensitive paralysis, suggesting that the DTS mutations
cause a dominant gain-of-function. To examine whether
any of the ATPalphaCJ alleles exhibit temperature-sensiti-
vity akin to other gain-of-function alleles we examined their
locomotor function when the ambient temperature was
acutely elevated. Only ATPalphaCJ10 exhibited tempera-
ture-sensitive paralysis. This phenotype was not observed
in young ATPalphaCJ10 Xies and manifested in a progres-
sive manner: Wrst evident at approximately 20 days post-
eclosion and becoming highly penetrant by day 30. The
average time to paralysis of day 20 ATPalphaCJ10 Xies
when acutely shifted to the non-permissive temperature
(38°C) was 334 § 17.3 s. Wild-type Xies and the remaining
ATPalphaCJ mutants did not paralyze in the 7-min test
period. The paralysis in ATPalphaCJ10 Xies was reversible:
recovery of normal locomotion in ATPalphaCJ10 took an
average of 209 § 35 s at the permissive temperature (room
temperature »22°C).
Circadian rhythms and locomotor function in ATPalpha 
alleles
We examined whether circadian rhythm or locomotor func-
tion in ATPalphaCJ mutants were aberrant using the DAM
system. ATPalphaCJ mutants, revertant animals, and age-
matched controls were examined at day 10–12 post-eclo-
sion. All of the ATPalpha mutant lines examined, except
ATPalphaCJ12, display normal waking activity levels: a
measure of total activity/total time active (Fig. 3a). The
ATPalphaCJ12 strain is more active than wild type in this
measure. In contrast, waking locomotor activity of ATPal-
phaCJ mutants in response to startle stimulation was
reduced from that of age-matched control animals (Fig. 3b).
It was noted that all ATPalphaCJ mutants did exhibit an
increased activity level upon startle stimulation but this
increase was signiWcantly less than that observed in wild-
type controls. Additionally, total activity levels and total
time active were signiWcantly reduced in ATPalphaCJ
mutants from that of controls, yet a normal circadian pat-
tern to their behavior is evident (Supplemental Fig. 3).
Thus, ATPalphaCJ mutants are less active but exhibit nor-
mal waking locomotor function at permissive temperatures.
These mutants exhibit circadian behavior and are also capa-
ble of responding to a startle stimulus; however, their star-
tle response locomotion is signiWcantly reduced, suggesting
a decrease in their maximal locomotion capacity.
Fig. 3 Locomotor impairment in ATPalpha alleles. Waking activity
levels (measured in total activity counts/total minutes active) were
determined for daytime baseline locomotor activity (a) and a 2-h peri-
od of repeated startle stimulation during a period of inactivity (b) for
heterozygous populations at 25°C (see “Materials and methods”). At
the age of testing (12–15 days) no gross locomotor deWcits were
observed in any line, and baseline waking activity levels were not sig-
niWcantly diVerent from ATPalphaDTS1R1 or wild type (ve e) except for
ATPalphaCJ12, which appeared to be signiWcantly hyperactive
(** P < 0.005). Upon stimulation, however, all ATPalpha mutant
strains display signiWcantly lower activity levels than wild type con-



























































Hum Genet (2009) 126:431–447 439Neuromuscular pathology in ATPalpha alleles
Familial hemiplegic migraine and RDP are two distinct
neurological diseases that manifest largely from missense
mutations in the genes encoding the alpha subunit of Na+,
K+ ATPases. It remains controversial whether pathology
is associated with chronic RDP or FHM diseases, espe-
cially FHM associated with epilepsy or convulsions. We
examined the integrity of the neuromuscular system of
aged ATPalpha mutants and control animals and discov-
ered allele-speciWc pathology (Fig. 4). Some ATPalphaCJ
alleles, namely ATPalphaCJ7, ATPalphaCJ10, ATPalphaCJ13,
exhibit marked vacuolar pathology throughout the brains of
these animals (Fig. 4; Table 2). ATPalphaCJ5, ATPalphaCJ6,
Fig. 4 Histopathology from ATPalpha alleles. a–g Brain histology
from aged ATPalphaCJ alleles and control tissues. b ATPalphaCJ12 ani-
mals exhibit modest neuropathology akin to that observed in aged
wild-type control brains (a). ATPalphaCJ13 and ATPalphaCJ10 exhibit
marked neuropathology as is evident by vacuolar and spongiform-like
neuropath throughout the neuropil and optic lobes (c and d, respec-
tively). e ATPalphaCJ7 exhibits a Wne vacuolar pathology that is more
clearly observed at higher magniWcation as seen in g (compare to panel
f from wild type). h–j Muscle histology from aged animals. Wild-type
and ATPalphaCJ5 mutants do not exhibit signiWcant myopathology in
aged specimens (h and j, respectively). I ATPalphaCJ12 do exhibit
pathology. Bars are all 100 m. Histopathology was obtained from













Table 2 Summary of ATPalpha allele phenotypes
Neurodeg. Neurodegeneration and is scored on a scale of 0–5 where 5 is marked neuropathology, Myodeg. myodegeneration. Protein is expression
levels. Respir. respiration
 indicates previously published data (Palladino et al. 2003), – indicates not tested
Genotype TS para BS para Respir. Protein Neurodeg. Myodeg. Longevity
Wild type No No ! ! 0–1 No !
DTS1R1 No Yes # # 2 No "
DTS1 Yes Mild # ! 4 – ##
DTS2 Yes Mild – ! 4 – #
CJ 4 No Yes ## ! 0–1 No !
CJ 5 No Yes ## ! 2 No !
CJ 6 No Yes ## # 1–2 No ""
CJ 7 No Yes # # 2–3 - !
CJ 10 Yes Yes ## ! 2–3 No #
CJ 12 No Yes # ! 1 Yes "
CJ 13 No Yes ## # 3 No !123
440 Hum Genet (2009) 126:431–447and ATPalphaDTS1R1 have mild neuropathology, whereas,
ATPalphaCJ4 and ATPalphaCJ12 have minimal neuropatho-
logy, similar to that commonly seen in aged wild-type con-
trol animals (Fig. 4; Table 2, and data not shown). Interest-
ingly, ATPalphaCJ10 and ATPalphaCJ13 exhibit large
clustering vacuolar pathology similar in appearance to that
seen in ATPalphaDTS mutants (Palladino et al. 2003). In
contrast, the neuropathology in ATPalphaCJ7 is a small non-
clustering vacuolar pathology similar to that reported in the
TPIsugarkill mutant strain (Celotto et al. 2006b). Histology
was also performed on Xight muscles from the ATPalphaCJ
mutants and only the ATPalphaCJ12 exhibit signiWcant myo-
pathology (Fig. 4i).
ATPalphaCJ alleles have decreased metabolic rates
The Na+, K+ ATPase is known to be broadly expressed,
exhibit high expression in the neuromuscular system and be
a major consumer of cellular energy. To test the hypothesis
that these ATPalpha mutants result in a loss of normal
ATPase function, we examined whole animal respiration
using a sensitive, well-established single Xy assay (Celotto
et al. 2006a; Van Voorhies et al. 2003, 2004). In all mutants
examined there is a signiWcant reduction in the rate of ani-
mal respiration versus age-matched control animals
(Fig. 5). Surprisingly, heterozygosity for the ATPalphaDTS1
mutation resulted in an »10% decrease in respiration, the
revertant strains produced an »15% reduction, and the
ATPalphaCJ mutants produced a 16–27% decrease in total
animal respiration. These data are consistent with the
ATPalphaCJ mutants representing a range of loss-of-func-
tion phenotypes from mild hypomorph to strong loss-of-
function.
ATPalphaCJ alleles maintain normal septate junction 
barrier and tracheal tube-size control function
In addition to its essential function as an ion pump, we have
previously shown that the Drosophila Na+, K+ ATPase also
has critical pump-independent structural or scaVolding
functions in septate junctions, which, like the vertebrate
tight junction, provide paracellular diVusion barriers
(Genova and Fehon 2003; Paul et al. 2003, 2007). To deter-
mine whether the ATPalphaCJ mutations aVect Na+, K+
ATPase septate junction function (ion-transport indepen-
dent) we examined paracellular barrier function and tra-
cheal tube morphogenesis in the new mutants using
established methods (Paul et al. 2007). ATPalphaCJ alleles
and two known null alleles, ATPalphaDTS1R1 or ATPal-
phaDTS1R2, were tested as homozygotes derived from hetero-
zygous parents. In addition, two ATPalphaCJ were tested in
trans with the null alleles (see “Materials and methods”).
We found that paracellular barriers formed in all ATPal-
phaCJ mutants (Table S1). Further, all ATPalphaCJ alleles
examined also supported normal tracheal formation, indi-
cating that apical secretion of the Verm protein was normal
(Fig. 6; Table S1). In contrast, ATPalphaDTS1R2 homozy-
gous animals cannot form paracellular barriers and show
Fig. 5 Animals heterozygous for ATPalpha alleles have reduced res-
piration. Respiration was measured from the emergent carbon dioxide
from individual ATPalpha mutants and age-matched wild-type con-
trols. ATPalpha mutants uniformly have signiWcantly lower metabolic
rates than controls. Error is SEM, n = 4–10, per genotype. Animals
were 5–6 days old adults. Statistical signiWcance was determined by
































Fig. 6 ATPalphaCJ alleles have normal septate junction function and
tracheal morphogenesis. a–b Heterozygous null alleles have normal
dorsal trunks and ganglionic branches. c–d ATPalphaCJ alleles in trans
with null alleles are also normal. e–f Homozygous null alleles demon-
strate a lengthened dorsal trunk and incomplete ganglionic branches.
Scale bars are 15 m123
Hum Genet (2009) 126:431–447 441elongated dorsal trunks (Fig. 6e) and gaps in the ganglionic
branches (Fig. 6f) that are not present in ATPalphaCJ
mutants (Fig. 6c, d; Table S1) or the heterozygous control
animals (Fig. 6a, b). These data demonstrate that none of
the tested ATPalphaCJ alleles are null alleles because they
retain signiWcant and perhaps normal tracheal size control
and barrier function activity. Rather, these alleles appear to
speciWcally aVect ion-transport functions of the Na+, K+
ATPase.
ATPalpha mutants display progressive, stress-sensitive 
paralysis
Numerous mutations aVecting ATPalpha have been shown
to result in varying degrees of conditional paralysis result-
ing from mechanical stress (Lebovitz et al. 1989; Palla-
dino et al. 2003; Schubiger et al. 1994; Sun et al. 2001;
Trotta et al. 2004). However, observations of young Xies
in our ATPalphaCJ mutants revealed no overt locomotor
defects—qualitatively all Xies displayed robust geotaxic
responses and appeared to walk, climb, and Xy normally.
We used a quantitative measure of stress-sensitive paraly-
sis to examine the locomotor function of ATPalpha
mutants as they age to determine whether this phenotype
was progressive. Young ATPalphaCJ Xies (3 days post-
eclosion) were tested for mechanical stress-induced
paralysis and none of the lines revealed a striking defect.
However, ATPalphaCJ5 and ATPalphaCJ10 did recover
more slowly from the stress than age-matched control ani-
mals (Fig. 7a). As the ATPalphaCJ mutant strains aged the
progressive nature of this locomotor defect became evi-
dent with all lines exhibiting marked paralysis that
resulted in a signiWcantly longer recovery time than age-
matched controls and with young animals of the same
Fig. 7 Longevity and stress-
sensitive locomotor impairment 
in ATPalpha alleles. a Progres-
sive locomotor impairment in 
heterozygous ATPalpha mu-
tants. Recovery from mechani-
cal stress-induced paralysis 
(seconds) was measured in ATP-
alpha mutants and aged-
matched wild type controls at 
25°C. Paralysis was never ob-
served in wild type controls, but 
all mutant lines showed some 
degree of progressive impair-
ment by 20–30 days post-eclo-
sion. Asterisks indicate 
signiWcant diVerences from age-
matched wild type controls us-
ing a Student’s t test 
(* P < 0.001). Time points 
examined are days 3, 10 and 30 
post-eclosion. b Lifespans were 
performed on heterozygous 
ATPalpha mutant and control 
animals. Median lifespan was 
used to compare longevity be-
tween the genotypes. Asterisks 
indicate signiWcant diVerences 
from wild type controls using a 
Student’s t test (* P < 0.05, 








































































442 Hum Genet (2009) 126:431–447genotype (Fig. 7a). There was some variability in severity
of the stress-sensitive paralysis and in the age of onset
between the ATPalphaCJ strains. All ATPalphaCJ mutants
exhibited 100% penetrance of this phenotype once they
were aged 15–30 days post-eclosion.
ATPalpha CJ alleles have diVerent eVects on lifespan
Previously, gain-of-function alleles of ATPalpha were
shown to have signiWcantly reduced longevity from that of
control animals (Palladino et al. 2003). The severity of
degenerative pathology observed in some ATPalphaCJ
mutants suggested that some of these alleles might also
have reduced longevity. We measured lifespans in all of
our new alleles as well as a cytologically normal revertant
strain ATPalphaDTS1R1. Only the ATPalphaCJ10 mutant
exhibited a reduction in longevity (data not shown). This
result is consistent with the severity of the stress-sensitive
locomotor impairment and marked neurodegenerative
pathology observed in this strain. Surprisingly, several
strains had signiWcantly increased longevity (data not
shown). To properly control for hybrid vigor and strain
eVects, we replicated these experiments using single out-
crossed mutant and controls lacking balancer chromosomes
and maintaining heterozygosity of w, ve, and e in all
mutants and in the control populations (see “Materials and
methods” for details). The increase observed in longevity
associated with the ATPalphaCJ6, ATPalphaCJ12 and in
ATPalphaDTS1R1 mutations was reproduced (Fig. 7b). The
ATPalphaCJ6 strain demonstrated a highly reproducible
22% increase longevity over the control strain. Importantly,
not all of the ATPalphaCJ mutants exhibit increased
longevity and the independently isolated ATPalphaDTS1R1
strain also has increased longevity, ruling out numerous
trivial explanations for this Wnding. The allele speciWcity of
the Wnding and the fact that the ATPalphaDTS1R1 strain has
increased longevity suggest that a speciWc level of ATPal-
pha impairment might be advantageous to animal
longevity.
Pharmacological phenocopy with ouabain
The Na+, K+ ATPase has numerous diverse functions
including ion transport and non-pumping functions. Activity
of the Na+, K+ ATPase is known to serve the essential
roles of maintaining ion gradients in numerous tissues,
including the neuromuscular system where high membrane
potentials are required for signaling and in numerous other
tissues where they are tied to various cellular homeostatic
processes. To conWrm that dose-dependent loss-of-function
of the Na+, K+ ATPase is responsible for modulating lon-
gevity, we utilized the well-characterized pharmacological
antagonist ouabain. These experiments allowed us to exam-
ine the eVect of varied Na+, K+ ATPase impairment within
a standardized control genotype (isogenic Canton S) to
completely control for genetic background. These experi-
ments revealed a dose-dependent increase in longevity,
where low doses exhibited the most striking increase in
lifespan (25%) and high doses exhibited toxicity, as pre-
dicted (Fig. 8). The Wnding that genetic and pharmacologic
impairment of the Na+, K+ ATPase each exhibit a similar
22–25% increase in longevity suggests an important role
for this protein in regulating organism lifespan. ATPalpha
mutant longevity and other phenotypes are summarized in
Table 2.
Caloric restriction mechanism of increased longevity?
Several Caenorhabditis elegans eat mutants were found to
have increased longevity, including eat-6 that encodes the
Na+, K+ ATPase alpha subunit (Hamilton et al. 2005;
Lakowski and Hekimi 1998). It was proposed that the
increase in longevity was due to the dramatic decrease in
their feeding rates thus inducing a state of caloric restric-
tion—a well-known method of increasing animal longevity
Fig. 8 Ouabain improves longevity in wild type animals. Longevity
assays were performed on wild-type animals administrated one of four
test doses of ouabain or vehicle. a The presence of ouabain altered sur-
vivorship and resulted in a right or left shift to the survival curve rela-
tive to the control, representing an increase or decrease, respectively. b
Median lifespan was used to compare the survival curves. Asterisks
indicate signiWcant diVerences from wild-type controls using a Stu-
























































Hum Genet (2009) 126:431–447 443(Lakowski and Hekimi 1998). We examined the mass of
the ATPalphaCJ animals and age- and gender-matched con-
trols to determine whether the animals were malnourished
akin to the eat-6 mutants. There was no reduction in the
mass of ATPalphaCJ mutant animals as is observed in eat-6
mutants (Supplemental Fig. 4). To more directly assess
nutrient intake in ATPalphaCJ mutants we utilized an estab-
lished Drosophila feeding assay (Edgecomb et al. 1994; Xu
et al. 2008). Animals were acutely nutrient deprived and
then provided media containing a dye that can be quantiWed
using a spectrophotometer. All of the ATPalphaCJ mutants
demonstrated robust ingestion of the test media (Fig. 9).
Although there was variability in consumption noted
between strains, none of the mutants examined showed a
marked reduction in feeding (Fig. 9). There was no correla-
tion between feeding and animal longevity (Pearson
r = 0.383) or between mass and longevity (Pearson
r = ¡0.308). Although the feeding assay media is distinct
from the standard Drosophila media used in longevity
assay, the feeding assay results clearly demonstrate the ani-
mals are all capable of normal levels of nutrient consump-
tion. Thus, the data argue that the increase in longevity
observed from loss of Na+, K+ ATPase function in
Drosophila is likely distinct from that reported for eat-6
mutants.
Discussion
Sodium potassium pumps were Wrst theorized almost
70 years ago (Dean 1941) and Wrst demonstrated biochemi-
cally over 50 years ago (Skou 1957), an achievement that
led to the shared Nobel prize in chemistry many years later
in 1997 (Skou 1998). For decades it was widely hypothe-
sized that mutations aVecting sodium pump genes might
cause various heritable neurological diseases; however,
many attempts to link such diseases to mutations in these
genes were not successful. The extremely high degree of
evolutionary conservation of Na+, K+ ATPase alpha sub-
units and their indispensable role in numerous essential
processes led some researchers to wonder whether these
genes could be targets of genetic disease. Reports of Dro-
sophila sodium pump mutants with stress-sensitive paraly-
sis and ouabain sensitivity (Lebovitz et al. 1989), and later
those with temperature-dependent paralysis, reduced lon-
gevity and neural degeneration (Palladino et al. 2003), sug-
gested that sodium pump loci were capable of mutations
that could result in neurological disease-like states, at least
in invertebrates. Later in 2003 the Wrst human disease,
FHM, was mapped to the ATP1A2 locus (De Fusco et al.
2003) and a year later several RDP mutations were mapped
to the ATP1A3 locus (de Carvalho Aguiar et al. 2004). Cur-
rently more than 40 human disease-causing sodium pump
mutations are known to be associated with one of these two
neurological conditions or a variant thereof. In accordance
with the high degree of evolutionary conservation of these
proteins and their numerous essential cellular functions,
disease-causing mutations are dominantly inherited, mis-
sense mutations thought to confer a mild hypomorphic loss-
of-function condition.
Several Drosophila ATPalpha mutations have previ-
ously been reported; however, most of these are transpo-
son-induced or inversion breaks within the locus and it was
not evident that these would accurately model RDP and
FHM diseases resulting from numerous distinct missense
mutations. There is compelling evidence that dominant,
loss-of-function, missense mutations result in the RDP and
FHM diseases (de Carvalho Aguiar et al. 2004; De Fusco
et al. 2003). We sought to perform a genetic screen to iden-
tify novel EMS induced alleles of the ATPalpha gene, in
the hopes that an allelic series of loss-of-function mutations
would emerge to serve as animal models of these neurologi-
cal diseases and enable structure–function studies in a trac-
table genetic system. The screen produced seven new
useful alleles aVecting the Na+, K+ ATPase, six of which
were missense mutations. These ATPalphaCJ mutants all
exhibit reduced respiration consistent with each resulting in
a loss of ATPase ion-transport function. Several alleles
exhibit reduced ATPalpha protein by western blot, also
consistent with these being loss-of-function alleles. All of
the ATPalphaCJ mutants have normal or near normal sep-
tate junction barrier and tracheal morphogenesis function,
demonstrating that they are not null mutations and are
likely hypomorphic alleles aVecting other protein functions.
Fig. 9 Drosophila feeding assays. Feeding was measured as 625 nm
absorption owing to dye included in the test media. The ATPalphaCJ6
strain consumed signiWcantly more media than controls and the posi-
tive control strain consumed signiWcantly less. n = 2–3 groups per
genotype, representing 60–90 animals. Error is standard deviation.
* P < 0.01 and ** P < 0.001 (Student’s t test). All genotypes con-
sumed a signiWcant amount of media and their absorption was in the
linear range of detection. Genotypes tested were young age-matched
adults (days 3–5)






























444 Hum Genet (2009) 126:431–447Because of the tetramer organization of the mature Na+, K+
ATPase, hypomorphic loss-of-function mutations have the
potential to be more severe than protein null mutations due
to possible dominant-negative eVects. Such a mutation may
exert a dominant-negative eVect functionally on the mature
ATPase or by altering protein assembly, traYcking, or sta-
bility. Dependent upon the mechanism of action and the
eYciency of protein degradation, protein abundance may
not be signiWcantly altered as determined by western blot.
Further studies will be needed to more deWnitively establish
the nature of these mutations; however, these mutations
provide important tools for studying the multiple ion-trans-
port dependent and independent functions of the Na+, K+
ATPase.
We have extensively characterized locomotor function
and behavior in these mutants. All of the novel mutants
exhibit circadian behavior and are capable of normal wak-
ing locomotor function. Total activity of ATPalphaCJ
mutants is reduced. The Drosophila startle response causes
increased locomotor activity in wild-type strains, and in
ATPalphaCJ mutants, however to a lesser extent in these
mutants. These data suggest that ATPalphaCJ mutants have
a speciWc defect aVecting intensive or maximal activity.
Gain-of-function alleles have previously been isolated that
exhibit temperature-dependent paralysis. Of these new
alleles, only the ATPalphaCJ10 mutant exhibits temperature-
sensitive paralysis. One perplexing but characteristic
feature of RDP is that while the disease is progressive, its
onset is rapid and often follows a physical stress. We exam-
ined stress-dependent locomotor function in ATPalphaCJ
mutants and found that all of the ATPalphaCJ mutants
exhibit this feature and the dysfunction that manifests
increases markedly with time after the initial onset.
We examined ATPalphaCJ mutants for pathology within
the neuromuscular system. We discovered neuropathology
associated with speciWc missense mutations. Neuropathology
was most severe in ATPalphaCJ7, ATPalphaCJ10 and
ATPalphaCJ13. We had previously reported temperature-sen-
sitive alleles that exhibit marked neuropathology and ATPal-
phaCJ10 also exhibits temperature-sensitive paralysis. These
results suggest that the speciWc gain-of-function that confers
temperature-sensitivity is neurotoxic: understanding patho-
genicity of this gain-of-function will require additional
study. Interestingly, neuropathology exhibits allelic varia-
tion and many of the ATPalphaCJ mutants do not exhibit
neuropathology or the pathology observed is mild, whereas
other mutants exhibit marked neuropathology, including
ATPalphaCJ7, ATPalphaCJ10, ATPalphaCJ13, ATPalphaDTS1,
and ATPalphaDTS2. The ATPalphaCJ13 missense mutation
results in the identical amino acid substitution to the protein
(A588T) as is known to cause FHM (A606T in ATP1A2).
This mutant will serve as a valuable model to elucidate the
speciWc dysfunction associated with FHM pathogenesis.
ATPalphaDTS2 aVects the aspartic acid amino acid 981. This
amino acid is also known to be aVected in FHM patients
bearing the D999H mutation. There is limited data regarding
long-term pathology in RDP and FHM patients, the data
presented here suggest that speciWc missense alterations
aVecting the ATP1A proteins are capable of being neuro-
pathogenic, which should be investigated further.
It was surprising to Wnd that speciWc alleles of ATPalpha
increase longevity by as much as 25% in the absence of a
decrease in animal weight or a defect in feeding as was
reported for C. elegans eat-6 mutants (Lakowski and
Hekimi 1998). Na+, K+ ATPases have been implicated in
numerous essential cellular homeostatic processes, making
it surprising that mild hypomorphic loss-of-function muta-
tions aVecting this protein would result in increased longevity.
Whether genetic or pharmacological, impairment of the
Na+, K+ ATPase was found to increase the median lifespan
by »20–25%. The sodium pump is actively involved in
numerous cellular processes in the brain as well as in other
organ systems. Thus, the increase in longevity could derive
from altered metabolic activity, stress-response, insulin sig-
naling, or decreased sensory input (or capacity) similar to
results in other C. elegans and Drosophila aging models
(Antebi 2007; Giannakou and Partridge 2007; Libert et al.
2007; Samuelson et al. 2007; Tatar 2007; Tatar et al. 2001;
Vermeulen and Loeschcke 2007). It is also possible that a
novel mechanism of action or combination of mechanisms
underlies the observed increase in longevity.
A plethora of human sodium pump mutations have been
identiWed recently: more than 40 described mutations are
known that aVect the ATP1A2 and ATP1A3 proteins. Why
are there so many distinct mutations in the ATP1A genes?
The genes are large, »28 kb genetic loci with »3.6 kb
mRNAs containing »1,000 codons, but the size of the genes
does not seem to fully explain the observed incidence.
Numerous processes are known to determine the frequency
of disease mutations, namely: mutation rate, selection,
genetic drift, and founder eVects and suYcient data does not
currently exist to determine the role, if any, of these factors.
Systematic and detailed studies will be needed to understand
whether mutation rates of ATP1A genes are increased. It is
possible that the large number of mutations, especially those
causing FHM, exist simply due to the dominant loss-of-
function nature of mutations that cause this disease. The lack
of any obvious decrease in Wtness is also relevant. The high
degree of evolutionary conservation of Na+, K+ ATPases
suggests that there is signiWcant functional constraint as
well. Although speculative, it is possible that certain ATP1A
mutations exhibit antagonistic pleiotropy and confer an
advantage to the aVected individuals or at least do so under
certain situations and that this contributes to their preponder-
ance. The Wnding that several mild hypomorphic mutations
do not cause pathology and confer an increase in longevity123
Hum Genet (2009) 126:431–447 445suggests the existence of some signiWcant beneWt associated
with mutation in ATP1A genes.
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